Search research articles
Contact Us
Filters
Showing results (11-20 of 91) with videos related to
Page
of 10
Sort By:
Immunological Reviews
|
November 24, 1999
Therapeutic vaccines in HIV.1 infection
F Gotch, G Hardy, N Imami
The Journal of Experimental Medicine
|
December 1, 1988
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site
F Gotch, A McMichael, J Rothbard
Expert Opinion on Biological Therapy
|
December 1, 2001
Development of immunotherapeutic strategies for HIV-1
N Imami, G Hardy, F Gotch
Transactions - American Society for Artificial Internal Organs
|
January 1, 1972
Comparative solute transport and therapeutic effectiveness of multiple point support and standard Kiil hemodialyzers
H Edson, M Keen, F Gotch
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 1, 1993
The measured creatinine generation rate in CAPD suggests only 78% of prescribed dialysis is delivered
M Keen, B Lipps, F Gotch
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
November 14, 1997
Early initiation of chronic dialysis: role of incremental dialysis
R Mehrotra, K D Nolph, F Gotch
Immunogenetics
|
January 1, 1996
Identification of a new HLA-A allele (A*2502) by PCR-SSP
P Krausa, D M Young, F Gotch
The Journal of Experimental Medicine
|
February 1, 1987
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes
F Gotch, A McMichael, G Smith, et al.
Contributions to Nephrology
|
January 1, 1989
Kinetics of beta-2-microglobulin in hemodialysis
F Gotch, N Levin, G Zasuwa, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 1, 1993
CAPD prescription in current clinical practice
F Gotch, D E Gentile, P Y Schoenfeld
Page
of 10
Search research articles
Search
Showing results (11-20 of 91) with videos related to
Sort By:
Page
of 10
Immunological Reviews
|
November 24, 1999
Therapeutic vaccines in HIV.1 infection
F Gotch, G Hardy, N Imami
The Journal of Experimental Medicine
|
December 1, 1988
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site
F Gotch, A McMichael, J Rothbard
Expert Opinion on Biological Therapy
|
December 1, 2001
Development of immunotherapeutic strategies for HIV-1
N Imami, G Hardy, F Gotch
Transactions - American Society for Artificial Internal Organs
|
January 1, 1972
Comparative solute transport and therapeutic effectiveness of multiple point support and standard Kiil hemodialyzers
H Edson, M Keen, F Gotch
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 1, 1993
The measured creatinine generation rate in CAPD suggests only 78% of prescribed dialysis is delivered
M Keen, B Lipps, F Gotch
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
November 14, 1997
Early initiation of chronic dialysis: role of incremental dialysis
R Mehrotra, K D Nolph, F Gotch
Immunogenetics
|
January 1, 1996
Identification of a new HLA-A allele (A*2502) by PCR-SSP
P Krausa, D M Young, F Gotch
The Journal of Experimental Medicine
|
February 1, 1987
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes
F Gotch, A McMichael, G Smith, et al.
Contributions to Nephrology
|
January 1, 1989
Kinetics of beta-2-microglobulin in hemodialysis
F Gotch, N Levin, G Zasuwa, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 1, 1993
CAPD prescription in current clinical practice
F Gotch, D E Gentile, P Y Schoenfeld
Page
of 10